Product Information
MESALAMINE DR 1.2 GM TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.7953 per EA under NDC 62135071460. Its NADAC has been published 147 times since Nov 1, 2023.
FDA first approved this application on May 12, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1.2 g/1
Manufacturer
Chartwell RX LLCNDC
62135071460
Classification
Generic
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
MESALAMINEApproval Type
Generic (ANDA)
FDA Application
ANDA217337FDA Approved
5/12/2023
TE Code
AB
On Market Since
6/3/2023
Pharmacological Classes
Price Statistics
The NADAC for MESALAMINE DR 1.2 GM TABLET has been published 147 times since Nov 1, 2023, and over the history we have for it it has declined 58.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7953 per EA |
|---|---|
| All-time high | $2.0543 (Feb 14, 2024) |
| All-time low | $0.7953 (Aug 19, 2026) |
| 52-week high | $1.0716 |
| 52-week low | $0.7953 |
| Median price | $1.1369 |
| Average price | $1.2161 |
| Largest weekly change | +45.9% (Aug 21, 2024) |
| Weeks tracked | 147 |
| Tracking since | Nov 1, 2023 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MESALAMINE DR 1.2 GM TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MESALAMINE DR 1.2 GM TABLET, manufactured by Chartwell RX LLC, is $0.7953 per EA (NDC 62135071460), effective Aug 19, 2026.
How has the price of MESALAMINE DR 1.2 GM TABLET changed over time?
Over the history we have for it, the NADAC for MESALAMINE DR 1.2 GM TABLET has declined 58.9%. It has been tracked across 147 weekly CMS publications since Nov 1, 2023.
What are the highest and lowest recorded NADAC prices for MESALAMINE DR 1.2 GM TABLET?
Since Nov 1, 2023, the NADAC for MESALAMINE DR 1.2 GM TABLET has ranged from a low of $0.7953 (Aug 19, 2026) to a high of $2.0543 (Feb 14, 2024), with a median of $1.1369 per EA.
Are there cheaper alternatives to MESALAMINE DR 1.2 GM TABLET?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MESALAMINE DR 1.2 GM TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures MESALAMINE DR 1.2 GM TABLET?
MESALAMINE DR 1.2 GM TABLET (NDC 62135071460) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.